Published on 29 May 2024 on Zacks via Yahoo Finance
Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Shares of this world's biggest maker of health care products have returned -0.2% over the past month versus the Zacks S&P 500 composite's +4.3% change. The Zacks Large Cap Pharmaceuticals industry, to which Johnson & Johnson belongs, has gained 3.4% over this period. Now the key question is: Where could the stock be headed in the near term?